Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-02 · accession 0001061983-22-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-02 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +30.0K | 178.0K | +20% | $0 |
| D | 2022-03-03 | 2022-03-02 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $37.63 | -5,004 | 148.0K | -3% | -$188.3K |
| DM | 2022-03-03 | 2022-03-02 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $37.63 | +70.0K | 66.6K | New | +$2.63M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | A | A | 30,000 | $0.00 | 178,000 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-02 | F | D | 5,004 | $37.63 | 148,000 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (right to buy) | 2022-03-02 | A | A | 3,379 | $37.63 | 3,379 | D | $37.63 · — to 2032-03-01 | 3,379 Common Stock | (F3) This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-02 | A | A | 66,621 | $37.63 | 66,621 | D | $37.63 · — to 2032-03-01 | 66,621 Common Stock | (F3) This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. |